BioTech
Bluebird Bio is laying off 25% of its workers to cut costs
Gene therapy company Bluebird Bio on Tuesday announced a 25% reduction of its workforce as part of a restructuring meant to save money as it
Stella Tannenbaum — The Boston Globe
September 24, 2024